Important matters:
Roboco (03757) plans to sell 11.876 million shares globally to bring in cornerstone investors such as Temasek and E-Fonda
Tongcheng New Materials (09607) plans to sell 68,187 million shares globally to introduce cornerstone investors such as CNBC Investment and Pulin Chengshan Hong Kong
Jingwang Electronics (03228) plans to sell 72.944,300 shares globally to introduce cornerstone investors such as Zhongji Xuchuang and E-Fangda Fund
Benmao Technology (06731) plans to sell 50 million shares globally and is expected to be listed on September 29
Starlink Technology (06727): Hong Kong Public Sale Receives 73.86x Subscription to Net HK$629 Million in Global Offering
Cordi-B (02487): CU-40102 (topical finasteride spray) was approved for marketing by the Macau Drug Administration
Hoyu B (02256): Hoyu Pharmaceuticals Announces Positive Preliminary Results of Phase II Clinical Study of Lavengratinib (ABSK061) for the Treatment of Achondroplasia
Pharmaceutical Jieankang-B (02617): Gentec® (tengotinib) was included in the CSCO Guidelines for the Diagnosis and Treatment of Biliary Malignancies (2026)
Shandong Xinhua Pharmaceutical Co., Ltd. (00719): Obtained the drug registration certificate for levocarnitine oral solution
Fubo Group (03738): Officially Released SeeBay™ “AI Content Creation+IP Asset Global Monetization” One-stop Industrial Platform
Yunfeng Financial (00376) restructuring the licensed entity structure will sell all of YFML's issued share capital
Andeley Juice (02218) plans to acquire 62.0611% of Ningbo Yongqiang Technology's shares for 793 million yuan
Jingtai Holdings (02228): Chairman Wen Shuhao plans to increase the company's shares
Bank of Guizhou (06199) plans to issue no more than 2,473 million domestic shares and no more than 43,900 H shares
Operating performance:
SF Holdings (06936)'s total revenue from express logistics business, supply chain and international business in August was 25.489 billion yuan, an increase of 2.83% over the previous year
Rongxin China (03301)'s total contract sales for the first 8 months were about 1,731 billion yuan, a year-on-year decrease of 35.89%